The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden
Open accessAbstract
Background: Early life antibiotics have been linked to childhood inflammatory bowel disease (IBD), but data on adults is mixed—particularly for ulcerative colitis (UC)—and is based on smaller investigations that have not assessed risk among siblings with shared genetic/environmental risk factors. Our objective was to determine the association of antibiotic therapy and IBD in a large, population-based investigation. Methods: We conducted a population-based prospective case-control study of individuals aged ≥16 years in ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden), the Swedish Patient Register, and the Prescribed Drug Register to identify all consecutive cases of incident IBD (2007–2016) based on histology and ≥1 diagnosis code for IBD or its subtypes: UC and Crohn’s disease (CD). Cumulative antibiotic dispensations accrued until one year prior to the time of matching for both study cases and up to five general population controls matched on the basis of age, sex, county, and calendar year. We also included unaffected full siblings as a secondary control group. Conditional logistic regression was used to estimate multivariable-adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Findings: We identified 23,982 new IBD cases (15,951 UC, 7,898 CD, 133 IBD-unclassified), 28,732 siblings, and 117,827 controls. Prior use of antibiotics (never vs. ever) was associated with a nearly two-times increased risk of IBD after adjusting for several risk factors (aOR 1·94, 95% CI: 1·85–2·03). Compared to none, one (aOR 1·11, 95% CI: 1·07–1·15), two (aOR 1·38, 95% CI: 1·32–1·44) , and ≥three antibiotic dispensations (aOR 1·55, 95% CI: 1·49–1·61) were associated with increased odds of IBD compared to controls. Increased risk was noted for UC and CD with the highest estimates corresponding to broad-spectrum antibiotics. Notably, comparable, but attenuated results were observed when siblings served as the referent (aOR 1·35, 95% CI: 1·28–1·43). Interpretation: Higher cumulative exposure to systemic antibiotic therapy, particularly those with greater spectrum of microbial coverage, may be associated with an increase in risk for new-onset IBD and its subtypes. The association between antimicrobial treatment and IBD did not appear to differ when comparably predisposed siblings were used as the referent controls. Funding: National Institutes of Health; Crohn’s and Colitis Foundation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Self-citationGlobal increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143
Self-citationDesai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., Pudlo, N. A., Kitamoto, S., Terrapon, N., Muller, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.043 · Cited by 2,805
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Kaplan, G. G., & Ng, S. C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.020 · Cited by 1,224
Hou, J. K., Abraham, B., & El-Serag, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.44 · Cited by 1,009
Recovery of gut microbiota of healthy adults following antibiotic exposure
Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0257-9 · Cited by 875
Rivera-Chávez, F., Zhang, L. F., Faber, F., Lopez, C. A., Byndloss, M. X., Olsan, E. E., Xu, G., Velazquez, E. M., Lebrilla, C. B., Winter, S. E., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.004 · Cited by 864
Cited by
Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Cai, Z., Wang, S., & Li, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.765474 · Cited by 675
Gut–liver axis: barriers and functional circuits
Pabst, O., Hornef, M. W., Schaap, F. G., Cerovic, V., Clavel, T., & Bruns, T. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00771-6 · Cited by 436
Antibiotic perturbations to the gut microbiome
Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440
“…and metabolic pathway architecture of the gut microbial community (referred to as dysbiosis) have been associated with an increased risk of numerous human pathologies, including inflammatory bowel disease 5 , obesity 6 , colorectal cancer 7,8 and numerous gastrointestinal infections 9–11 .”
BackgroundInfluentialAdaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
Ludvigsson, J. F., Appelros, P., Askling, J., Byberg, L., Carrero, J.-J., Ekström, A. M., Ekström, M., Smedby, K. E., Hagström, H., James, S., et al. (2021) · Clinical Epidemiology · doi:10.2147/clep.s282475 · Cited by 284
Self-citation
Metadata
- Authors
- Nguyen, L. H., Örtqvist, A. K., Cao, Y., Simon, T. G., Roelstraete, B., Song, M., Joshi, A. D., Staller, K., Chan, A. T., Khalili, H., Olén, O., & Ludvigsson, J. F.
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 5
- Issue
- 11
- Pages
- 986-995
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W3049009424
- Cited by
- 244
- References
- 12
- FWCI
- 17.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30267-3
- The paper
- Nguyen, L. H., Örtqvist, A. K., Cao, Y., Simon, T. G., Roelstraete, B., Song, M., Joshi, A. D., Staller, K., Chan, A. T., Khalili, H., Olén, O., & Ludvigsson, J. F. (2020). Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30267-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.